These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1412778)

  • 1. Inhibition of the proliferation of human thymocytes in vitro by rapamycin.
    Miller GA; Bansbach CC; Rabin M
    Transplantation; 1992 Oct; 54(4):763-5. PubMed ID: 1412778
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
    Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
    Luo H; Chen H; Daloze P; Chang J; Wu J
    Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of rapamycin (Sirolimus, Rapamune).
    Molnar-Kimber KL
    Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
    [No Abstract]   [Full Text] [Related]  

  • 7. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
    Degiannis D; Koniavitou K
    Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 11. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin: in vitro profile of a new immunosuppressive macrolide.
    Sehgal SN; Bansbach CC
    Ann N Y Acad Sci; 1993 Jun; 685():58-67. PubMed ID: 8363266
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
    Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
    Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin inhibits lymphocyte proliferation in a popliteal lymph node model via an IL-2-independent mechanism.
    Warner LM; Lewis GM; Weichman BM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():117-20. PubMed ID: 8363215
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro.
    Salas-Prato M; Assalian A; Mehdi AZ; Duperré J; Thompson P; Brazeau P
    J Glaucoma; 1996 Feb; 5(1):54-9. PubMed ID: 8795734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay.
    Kimball P; Kerman RH; Williams J; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
    Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.